Cytosorbents Corp Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q1 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cytosorbents Corp quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q1 2025.
  • Cytosorbents Corp Entity Common Stock, Shares Outstanding for the quarter ending March 31, 2025 was 62.5M shares, a 15.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 62.5M +8.21M +15.1% Mar 31, 2025 10-K 2025-03-31
Q3 2024 54.7M +10.2M +23% Nov 5, 2024 10-Q 2024-11-07
Q2 2024 54.4M +10.1M +22.7% Aug 12, 2024 10-Q 2024-08-13
Q1 2024 54.3M +10.6M +24.3% Mar 3, 2024 10-K 2024-03-15
Q3 2023 44.4M +803K +1.84% Nov 8, 2023 10-Q 2023-11-09
Q2 2023 44.4M +785K +1.8% Aug 1, 2023 10-Q 2023-08-01
Q1 2023 43.7M +157K +0.36% Mar 7, 2023 10-K 2023-03-09
Q3 2022 43.6M +160K +0.37% Nov 2, 2022 10-Q 2022-11-03
Q2 2022 43.6M +208K +0.48% Aug 1, 2022 10-Q 2022-08-02
Q1 2022 43.5M +242K +0.56% Mar 9, 2022 10-K 2022-03-10
Q3 2021 43.5M +300K +0.7% Nov 2, 2021 10-Q 2021-11-04
Q2 2021 43.4M +211K +0.49% Aug 3, 2021 10-Q 2021-08-03
Q1 2021 43.3M +8.21M +23.4% Mar 9, 2021 10-K 2021-03-09
Q3 2020 43.2M +10.8M +33.2% Nov 2, 2020 10-Q 2020-11-04
Q2 2020 43.2M +10.9M +33.6% Jul 31, 2020 10-Q 2020-08-04
Q1 2020 35.1M +2.8M +8.69% Mar 2, 2020 10-K 2020-03-05
Q3 2019 32.4M +772K +2.44% Nov 4, 2019 10-Q 2019-11-05
Q2 2019 32.3M +844K +2.68% Aug 5, 2019 10-Q 2019-08-06
Q1 2019 32.2M +2.78M +9.43% Apr 30, 2019 10-Q 2019-05-07
Q3 2018 31.7M +2.96M +10.3% Oct 31, 2018 10-Q 2018-11-06
Q2 2018 31.5M +3.33M +11.8% Jul 31, 2018 10-Q 2018-08-02
Q1 2018 29.5M +3.95M +15.5% Feb 28, 2018 10-K 2018-03-08
Q3 2017 28.7M +3.22M +12.7% Nov 7, 2017 10-Q 2017-11-09
Q2 2017 28.1M +2.7M +10.6% Aug 2, 2017 10-Q 2017-08-07
Q1 2017 25.5M +118K +0.46% Feb 28, 2017 10-K 2017-03-03
Q3 2016 25.5M +103K +0.41% Nov 3, 2016 10-Q 2016-11-07
Q2 2016 25.4M +391K +1.56% Aug 3, 2016 10-Q 2016-08-09
Q1 2016 25.4M +768K +3.12% Mar 4, 2016 10-K 2016-03-09
Q3 2015 25.4M -556M -95.6% Nov 10, 2015 10-Q 2015-11-13
Q2 2015 25M -286M -91.9% Aug 10, 2015 10-Q 2015-08-13
Q1 2015 24.6M -274M -91.7% Mar 23, 2015 10-K 2015-03-31
Q3 2014 582M +337M +137% Nov 7, 2014 10-Q 2014-11-12
Q2 2014 311M +65.6M +26.7% Aug 6, 2014 10-Q 2014-08-12
Q1 2014 299M +69.6M +30.4% Mar 14, 2014 10-K 2014-03-31
Q3 2013 245M Nov 5, 2013 10-Q 2013-11-06
Q2 2013 245M +42.2M +20.8% Aug 12, 2013 10-Q 2013-08-14
Q1 2013 229M +39.8M +21.1% Apr 1, 2013 10-K 2013-04-03
Q4 2012 212M Nov 21, 2012 10-Q 2012-11-21
Q2 2012 203M +35.6M +21.3% Aug 8, 2012 10-Q 2012-08-13
Q1 2012 189M Mar 28, 2012 10-K 2012-03-30
Q3 2011 177M Nov 14, 2011 10-Q 2011-11-14
Q2 2011 167M Aug 12, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.